Arcutis Biotherapeutics Ratios (2020-2025) | ARQT

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 62.90%83.62%71.84%85.05%96.06%83.39%93.43%88.77%87.70%90.32%86.59%90.81%91.25%
EBT Margin 3,507.40%3,391.35%-14,856.41%-2,432.25%-2,880.26%-1,367.84%-139.14%-489.86%-70.73%-169.59%-92.81%-14.67%-37.63%-19.07%7.55%
EBIT Margin 3,407.40%3,291.35%-14,448.00%-2,310.84%-2,742.36%-1,286.38%-123.01%-452.23%-63.79%-162.28%-87.29%-10.70%-37.25%-17.93%8.59%
EBITDA Margin 3,541.29%3,381.90%-14,903.86%-2,415.03%-2,856.09%-1,365.49%-148.86%-488.66%-71.66%-170.11%-90.96%-15.87%-38.26%-19.36%7.44%
Operating Margin 3,407.40%3,291.35%-14,448.00%-2,310.84%-2,742.36%-1,286.38%-123.01%-452.23%-63.79%-162.28%-87.29%-10.70%-37.25%-17.93%8.59%
Net Margin 3,507.40%3,391.35%-14,856.41%-2,432.25%-2,880.26%-1,367.84%-149.22%-490.05%-71.38%-169.59%-92.81%-15.12%-38.06%-19.49%7.47%
FCF Margin 3,106.58%3,103.00%-9,338.07%-2,404.19%-2,891.98%-1,286.34%-146.83%-415.87%-63.76%-146.21%-77.83%-1.05%-47.06%0.30%-1.77%
Efficiency
Inventory Average 5.91M8.03M9.51M12.19M13.52M13.19M13.56M13.95M14.27M15.57M16.47M19.37M
Assets Average 243.18M214.99M248.14M384.84M452.15M409.95M397.58M386.13M332.29M404.69M479.09M414.37M350.07M306.82M317.16M409.95M461.65M441.06M393.12M346.50M348.27M361.70M
Equity Average 225.40M191.00M221.85M360.81M432.74M388.74M330.34M275.72M224.58M233.08M240.18M174.66M110.12M63.61M67.69M156.80M205.68M171.53M157.09M150.10M140.82M148.52M
Invested Capital 241.88M208.92M173.07M270.62M450.99M414.49M363.00M370.03M326.51M268.52M467.53M407.35M338.50M280.27M247.50M290.47M427.75M390.24M361.25M264.74M250.28M247.02M266.57M
Asset Utilization Ratio 0.000.010.030.130.160.240.270.310.500.610.760.88
Leverage & Solvency
Interest Coverage Ratio -34.07-32.91-21.38-9.90-10.83-9.08-4.88-7.88-4.23-6.69-5.87-1.37-8.23-4.822.78
Debt to Equity 0.240.290.370.730.941.422.484.302.280.901.091.310.680.750.780.69
Debt Ratio 0.180.200.240.390.440.520.620.690.590.420.460.470.310.310.310.29
Equity Ratio 0.950.900.870.910.960.960.940.730.700.650.530.470.370.250.160.260.470.420.360.450.410.390.43
Times Interest Earned -34.07-32.91-21.38-9.90-10.83-9.08-4.88-7.88-4.23-6.69-5.87-1.37-8.23-4.822.78
Valuation
Enterprise Value 885.73M929.82M929.23M1,402.91M1,004.02M687.41M833.01M656.07M626.72M813.55M508.40M492.14M577.87M316.68M100.27M32.99M555.55M714.17M756.53M1,219.43M1,657.41M1,480.39M2,069.14M
Market Capitalization 1,135.05M1,153.79M1,118.95M1,687.35M1,448.95M1,096.78M1,200.28M1,043.12M970.32M1,095.72M985.36M901.73M910.28M585.35M327.38M304.85M959.42M1,076.61M1,087.09M1,447.39M1,855.50M1,671.21M2,260.21M
Return Ratios
Return on Sales -73.35%-28.38%-6.54%-5.09%-2.21%-1.60%-1.41%-0.71%-0.61%-0.35%-0.14%
Return on Capital Employed -0.57%-0.66%-0.84%-0.83%-0.68%-0.84%-1.01%-0.94%-0.89%-0.54%-0.44%-0.68%-0.41%-0.48%-0.35%-0.15%
Return on Assets -0.52%-0.61%-0.78%-0.77%-0.65%-0.79%-0.94%-0.87%-0.83%-0.53%-0.43%-0.44%-0.36%-0.37%-0.27%-0.12%
Return on Equity -0.63%-0.85%-1.16%-1.34%-1.30%-1.88%-3.00%-4.21%-3.87%-1.39%-0.97%-1.14%-0.89%-0.86%-0.66%-0.30%